Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-NICE: Nilotinib vs Imatinib in Ph+ CML
NCT01400074Phase 3Unknown
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Jan 2009
- Primary completion
- Jun 2014
- Countries
- 1
01
Overview
A Phase 3 trial of nilotinib in chronic myeloid leukemia (CML), sponsored by Seoul St. Mary's Hospital. Status: unknown.
02
Drugs
nilotinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT01400074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400074.